Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities.

contact precautions environmental surfaces healthcare environment healthcare-associated infections multidrug resistance

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
29 01 2021
Historique:
received: 18 08 2020
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 28 4 2021
Statut: ppublish

Résumé

Environmental contamination is an important source of hospital multidrug-resistant organism (MDRO) transmission. Factors such as patient MDRO contact precautions (CP) status, patient proximity to surfaces, and unit type likely influence MDRO contamination and bacterial bioburden levels on patient room surfaces. Identifying factors associated with environmental contamination in patient rooms and on shared unit surfaces could help identify important environmental MDRO transmission routes. Surfaces were sampled from MDRO CP and non-CP rooms, nursing stations, and mobile equipment in acute care, intensive care, and transplant units within 6 acute care hospitals using a convenience sampling approach blinded to cleaning events. Precaution rooms had patients with clinical or surveillance tests positive for methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, carbapenem-resistant Enterobacteriaceae or Acinetobacter within the previous 6 months, or Clostridioides difficile toxin within the past 30 days. Rooms not meeting this definition were considered non-CP rooms. Samples were cultured for the above MDROs and total bioburden. Overall, an estimated 13% of rooms were contaminated with at least 1 MDRO. MDROs were detected more frequently in CP rooms (32% of 209 room-sample events) than non-CP rooms (12% of 234 room-sample events). Surface bioburden did not differ significantly between CP and non-CP rooms or MDRO-positive and MDRO-negative rooms. CP room surfaces are contaminated more frequently than non-CP room surfaces; however, contamination of non-CP room surfaces is not uncommon and may be an important reservoir for ongoing MDRO transmission. MDRO contamination of non-CP rooms may indicate asymptomatic patient MDRO carriage, inadequate terminal cleaning, or cross-contamination of room surfaces via healthcare personnel hands.

Sections du résumé

BACKGROUND
Environmental contamination is an important source of hospital multidrug-resistant organism (MDRO) transmission. Factors such as patient MDRO contact precautions (CP) status, patient proximity to surfaces, and unit type likely influence MDRO contamination and bacterial bioburden levels on patient room surfaces. Identifying factors associated with environmental contamination in patient rooms and on shared unit surfaces could help identify important environmental MDRO transmission routes.
METHODS
Surfaces were sampled from MDRO CP and non-CP rooms, nursing stations, and mobile equipment in acute care, intensive care, and transplant units within 6 acute care hospitals using a convenience sampling approach blinded to cleaning events. Precaution rooms had patients with clinical or surveillance tests positive for methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, carbapenem-resistant Enterobacteriaceae or Acinetobacter within the previous 6 months, or Clostridioides difficile toxin within the past 30 days. Rooms not meeting this definition were considered non-CP rooms. Samples were cultured for the above MDROs and total bioburden.
RESULTS
Overall, an estimated 13% of rooms were contaminated with at least 1 MDRO. MDROs were detected more frequently in CP rooms (32% of 209 room-sample events) than non-CP rooms (12% of 234 room-sample events). Surface bioburden did not differ significantly between CP and non-CP rooms or MDRO-positive and MDRO-negative rooms.
CONCLUSIONS
CP room surfaces are contaminated more frequently than non-CP room surfaces; however, contamination of non-CP room surfaces is not uncommon and may be an important reservoir for ongoing MDRO transmission. MDRO contamination of non-CP rooms may indicate asymptomatic patient MDRO carriage, inadequate terminal cleaning, or cross-contamination of room surfaces via healthcare personnel hands.

Identifiants

pubmed: 33512527
pii: 6123354
doi: 10.1093/cid/ciaa1602
pmc: PMC8785946
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

S8-S16

Subventions

Organisme : NCRR NIH HHS
ID : UL1 RR025780
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Clin Microbiol Infect. 2011 Aug;17(8):1201-8
pubmed: 21054665
Appl Environ Microbiol. 2011 Dec;77(23):8355-9
pubmed: 21965403
Infect Control Hosp Epidemiol. 2008 Feb;29(2):149-54
pubmed: 18179370
Burns. 2018 Mar;44(2):272-279
pubmed: 29029861
J Hosp Infect. 2017 Jan;95(1):59-64
pubmed: 27771149
Arch Intern Med. 2003 Sep 8;163(16):1905-12
pubmed: 12963563
Infect Control Hosp Epidemiol. 2007 Oct;28(10):1142-7
pubmed: 17828690
Infect Control Hosp Epidemiol. 2011 Feb;32(2):185-7
pubmed: 21460476
Infect Control Hosp Epidemiol. 1997 Sep;18(9):622-7
pubmed: 9309433
Clin Microbiol Infect. 2018 Aug;24(8):877-881
pubmed: 29174729
Crit Care Med. 2017 Jul;45(7):e633-e639
pubmed: 28398924
J Hosp Infect. 2019 Feb;101(2):240-244
pubmed: 30500387
PLoS One. 2013 Sep 19;8(9):e76249
pubmed: 24069459
Crit Care Med. 2012 Apr;40(4):1045-51
pubmed: 22202707
World Hosp Health Serv. 2004;40(2):32, 34, 36-42
pubmed: 15338996
J Hosp Infect. 2017 Jan;95(1):76-80
pubmed: 27912981
J Clin Microbiol. 1994 May;32(5):1148-53
pubmed: 8051238
Infect Control Hosp Epidemiol. 2010 Jan;31(1):21-7
pubmed: 19929371
MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):235-41
pubmed: 26963489
J Hosp Infect. 2018 Jan;98(1):90-95
pubmed: 28964884
Am J Infect Control. 2009 Feb;37(1):15-9
pubmed: 19171247
BMC Infect Dis. 2013 Jul 24;13:342
pubmed: 23883171
Infect Control Hosp Epidemiol. 2013 May;34(5):517-20
pubmed: 23571370
JAMA. 2014 Oct 8;312(14):1447-55
pubmed: 25291580
Curr Opin Infect Dis. 2013 Aug;26(4):338-44
pubmed: 23743816
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
Clin Microbiol Rev. 2014 Oct;27(4):665-90
pubmed: 25278571
Ther Adv Infect Dis. 2014 Jun;2(3-4):79-90
pubmed: 25469234
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1426-1432
pubmed: 27619507
Am J Infect Control. 2013 May;41(5 Suppl):S105-10
pubmed: 23622740
Arch Intern Med. 2006 Oct 9;166(18):1945-51
pubmed: 17030826
Infect Control Hosp Epidemiol. 2018 Jan;39(1):40-45
pubmed: 29237512
Infect Control Hosp Epidemiol. 2013 May;34(5):500-6
pubmed: 23571367
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384

Auteurs

Windy D Tanner (WD)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
IDEAS Center, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.

Molly K Leecaster (MK)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
IDEAS Center, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.

Yue Zhang (Y)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.

Kristina M Stratford (KM)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
IDEAS Center, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.

Jeanmarie Mayer (J)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
IDEAS Center, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.

Lindsay D Visnovsky (LD)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
IDEAS Center, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.

Heba Alhmidi (H)

Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

Jennifer L Cadnum (JL)

Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

Annette L Jencson (AL)

Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

Sreelatha Koganti (S)

Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

Christina P Bennett (CP)

Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

Curtis J Donskey (CJ)

Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

Judith Noble-Wang (J)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sujan C Reddy (SC)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Laura J Rose (LJ)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Lauren Watson (L)

William S. Middleton Veterans Hospital, Madison, Wisconsin, USA.

Emma Ide (E)

William S. Middleton Veterans Hospital, Madison, Wisconsin, USA.

Tyler Wipperfurth (T)

William S. Middleton Veterans Hospital, Madison, Wisconsin, USA.

Nasia Safdar (N)

William S. Middleton Veterans Hospital, Madison, Wisconsin, USA.
University of Wisconsin, Madison, Madison, Wisconsin, USA.

Maria Arasim (M)

Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

Colleen Macke (C)

Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

Patti Roman (P)

Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.

Sarah L Krein (SL)

Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Catherine Loc-Carrillo (C)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
IDEAS Center, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.

Matthew H Samore (MH)

Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
IDEAS Center, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH